Article
Genetic instability influences drug response in cancer cells.
Current drug targets - 1 Oct 2010
Damia G, D'Incalci M
Abstract excerpt
One of the main reasons why most patients with advanced cancer are not curable with the therapies available is the broad heterogeneity of cancer cells, inherently related to their genomic instability that reflects defects of cell cycle checkpoints and DNA mismatch repair (MMR). The present paper reviews Today's knowledge of MMR. Microsatellite (DNA repetitive sequences) instability (MSI) used as a surrogate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
